Exercise Physiology Comprehensive Use of Cardiopulmonary Exercise Testing Identifies Adults With Congenital Heart Disease at Increased Mortality Risk in the Medium Term
نویسندگان
چکیده
Background—Parameters of cardiopulmonary exercise testing were recently identified as strong predictors of mortality in adults with congenital heart disease. We hypothesized that combinations of cardiopulmonary exercise testing parameters may provide optimal prognostic information on midterm survival in this population. Methods and Results—A total of 1375 consecutive adult patients with congenital heart disease (age, 33 13 years) underwent cardiopulmonary exercise testing at a single center over a period of 10 years. Peak oxygen consumption (peak V̇O2), ventilation per unit of carbon dioxide production (V̇E/V̇CO2 slope), and heart rate reserve were measured. During a median follow-up of 5.8 years, 117 patients died. Peak V̇O2, heart rate reserve, and V̇E/V̇CO2 slope were related to midterm survival in adult patients with congenital heart disease. Risk of death increased with lower peak V̇O2 and heart rate reserve. A higher V̇E/V̇CO2 slope was also related to increased risk of death in noncyanotic patients, whereas the V̇E/V̇CO2 slope was not predictive of mortality in cyanotic patients. The combination of peak V̇O2 and heart rate reserve provided the greatest predictive information after adjustment for clinical parameters such as negative chronotropic agents, age, and presence of cyanosis. However, the incremental value of these exercise parameters was reduced in patients with peak respiratory exchange ratio 1.0. Conclusions—Cardiopulmonary exercise testing provides strong prognostic information in adult patients with congenital heart disease. Prognostication should be approached differently, depending on the presence of cyanosis, use of rate-lowering medications, and achieved level of exercise. We provide 5-year survival prospects based on cardiopulmonary exercise testing parameters in this growing population. (Circulation. 2012;125:250-259.)
منابع مشابه
Comprehensive Use of Cardiopulmonary Exercise Testing Identifies Adults with Congenital Heart Disease at Increased Mortality Risk in the Medium Term Running title: Inunzuka et al.; Exercise testing in congenital heart disease
Background-Parameters of cardiopulmonary exercise testing (CPX) were recently identified as
متن کاملComprehensive use of cardiopulmonary exercise testing identifies adults with congenital heart disease at increased mortality risk in the medium term.
BACKGROUND Parameters of cardiopulmonary exercise testing were recently identified as strong predictors of mortality in adults with congenital heart disease. We hypothesized that combinations of cardiopulmonary exercise testing parameters may provide optimal prognostic information on midterm survival in this population. METHODS AND RESULTS A total of 1375 consecutive adult patients with conge...
متن کاملCardiopulmonary exercise testing in adults with congenital heart disease.
Adults with congenital heart disease (CHD) are at high risk for morbidity and mortality. Identifying those who are at highest risk of complications can be challenging, in part because self-reported functional status is not a reliable indicator of physiological status. Individuals with CHD may present with exercise limitation due to a variety of cardiac and non-cardiac causes. Cardiopulmonary ex...
متن کاملAngiopoietin-2 in Adults with Congenital Heart Disease and Heart Failure
BACKGROUND Chronic heart failure is an important cause for morbidity and mortality in adults with congenital heart disease (ACHD). While NT-proBNP is an established biomarker for heart failure of non-congenital origin, its application in ACHD has limitations. The angiogenic factors Angiopoietin-1 and -2 (Ang-1, Ang-2), vascular endothelial growth factor (VEGF), and soluble receptor tyrosine kin...
متن کاملAsymmetrical Dimethylarginine - More Sensitive than NT-proBNP to Diagnose Heart Failure in Adults with Congenital Heart Disease
BACKGROUND Chronic heart failure is an important cause for morbidity and mortality in adults with congenital heart disease (ACHD). While NT-proBNP is an established biomarker for heart failure of non-congenital origin, its value in ACHD has limitations. Asymmetrical dimethylarginine (ADMA) correlates with disease severity and independently predicts adverse clinical events in heart failure of no...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2012